Cargando…
Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
INTRODUCTION: Diabetic macular edema (DME) threatens daily life activities such as reading and driving and reduces the patients’ quality-of-life. Recently, anti-vascular endothelial growth factor (VEGF) agents have become a first-line therapy in DME. However, therapy with anti-VEGF agents has severa...
Autores principales: | Ishibashi, Ryoichi, Takatsuna, Yoko, Koshizaka, Masaya, Tatsumi, Tomoaki, Takahashi, Sho, Nagashima, Kengo, Asaumi, Noriko, Arai, Miyuki, Shimada, Fumio, Tachibana, Kaori, Watanabe, Yoshihiro, Ishikawa, Ko, Hoshino, Akiko, Yamamoto, Kyohei, Kubota-Taniai, Mariko, Mayama, Takafumi, Yamamoto, Shuichi, Yokote, Koutaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376811/ https://www.ncbi.nlm.nih.gov/pubmed/32542431 http://dx.doi.org/10.1007/s13300-020-00854-6 |
Ejemplares similares
-
Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020) -
Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
por: Tatsumi, Tomoaki, et al.
Publicado: (2022) -
Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017) -
Werner syndrome with refractory cystoid macular edema and immunohistochemical analysis of WRN proteins in human retinas
por: Oshitari, Toshiyuki, et al.
Publicado: (2014) -
One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
por: Sakurai, Madoka, et al.
Publicado: (2014)